- Home
- ZBH vs HOLX Comparison
ZBH vs HOLX Comparison
Compare ZBH & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZBH
- HOLX
- Stock Information
- Founded
- ZBH 1927
- HOLX 1985
- Country
- ZBH United States
- HOLX United States
- Employees
- ZBH N/A
- HOLX N/A
- Industry
- ZBH Industrial Specialties
- HOLX Medical Electronics
- Sector
- ZBH Health Care
- HOLX Health Care
- Exchange
- ZBH Nasdaq
- HOLX Nasdaq
- Market Cap
- ZBH 19.9B
- HOLX 16.5B
- IPO Year
- ZBH N/A
- HOLX 1990
- Fundamental
- Price
- ZBH $88.57
- HOLX $74.10
- Analyst Decision
- ZBH Buy
- HOLX Hold
- Analyst Count
- ZBH 19
- HOLX 15
- Target Price
- ZBH $109.00
- HOLX $79.00
- AVG Volume (30 Days)
- ZBH 2.1M
- HOLX 5.0M
- Earning Date
- ZBH 11-05-2025
- HOLX 11-03-2025
- Dividend Yield
- ZBH 1.08%
- HOLX N/A
- EPS Growth
- ZBH N/A
- HOLX N/A
- EPS
- ZBH 4.03
- HOLX 2.49
- Revenue
- ZBH $8,010,900,000.00
- HOLX $4,100,500,000.00
- Revenue This Year
- ZBH $8.20
- HOLX $6.23
- Revenue Next Year
- ZBH $5.92
- HOLX $5.37
- P/E Ratio
- ZBH $21.94
- HOLX $29.76
- Revenue Growth
- ZBH 5.47
- HOLX 1.74
- 52 Week Low
- ZBH $85.33
- HOLX $51.90
- 52 Week High
- ZBH $114.72
- HOLX $80.75
- Technical
- Relative Strength Index (RSI)
- ZBH 31.42
- HOLX 70.04
- Support Level
- ZBH $85.33
- HOLX $73.86
- Resistance Level
- ZBH $103.69
- HOLX $74.28
- Average True Range (ATR)
- ZBH 2.85
- HOLX 0.25
- MACD
- ZBH -1.53
- HOLX -0.05
- Stochastic Oscillator
- ZBH 15.03
- HOLX 29.07
About ZBH Zimmer Biomet Holdings Inc.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
About HOLX Hologic Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.